COVID-19 in IBD: The experience of a single tertiary IBD center

BACKGROUND: Italy has been one of the most affected countries in the world by COVID-19. There has been increasing concern regarding the impact of COVID‐19 on patients with inflammatory bowel disease (IBD), particularly in patients treated with immunosuppressants or biologics. The aim of our study is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzello, Fernando, Calabrese, Carlo, Salice, Marco, Calandrini, Lucia, Privitera, Hana, Melotti, Laura, Peruzzi, Giulia, Dussias, Nikolas, Belluzzi, Andrea, Scaioli, Eleonora, Decorato, Anastasio, Siniscalchi, Antonio, Filippone, Eleonora, Laureti, Silvio, Rottoli, Matteo, Poggioli, Gilberto, Gionchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2021
Materias:
Alimentary Tract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764386/
https://www.ncbi.nlm.nih.gov/pubmed/33451910
http://dx.doi.org/10.1016/j.dld.2020.12.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764386/
https://www.ncbi.nlm.nih.gov/pubmed/33451910
http://dx.doi.org/10.1016/j.dld.2020.12.012

Ejemplares similares